文献速递介入技术与安全MR

交错采集温度与纵向弛豫率图监测磁共振引导高强度聚焦超声热疗中的药物递送

Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance-Guided High-Intensity Focused Ultrasound-Induced Hyperthermia.
PubMed 文献 · Invest Radiol · 2017-01-01

在临床3-T MR-HIFU系统上,通过交错采集IR-LL R1图与PRFS测温序列,在体模、离体猪肌肉及9L胶质瘤大鼠中验证测温稳定性并评估R1变化与肿瘤多柔比星浓度的相关性,结果显示治疗期间平均ΔR1与多柔比星浓度线性相关(n=8,Radj=0.933)。

要点

  • 交错采集IR-LL R1图与PRFS测温未降低测温速度或精度。
  • 治疗期间平均ΔR1与肿瘤多柔比星浓度线性相关(n=8,Radj=0.933)。
  • 治疗期间ΔR1较肿瘤冷却后ΔR1更好地反映瘤内多柔比星浓度。

核心结论

  • 交错采集不同MR序列可在反馈控制的MR-HIFU热疗中同时获取R1图与PRFS测温,未损害各扫描的速度或准确性;治疗期间ΔR1用于可视化和量化热触发钆特醇释放,较冷却后ΔR1更好地反映瘤内多柔比星浓度。

研究设计与样本

  • 离体验证实验与在体概念验证研究,在临床3-T MR-HIFU系统配合临床前装置上完成;体模与离体猪肌肉组织评估R1值有效性和测温图稳定性;在体使用荷9L胶质瘤后肢大鼠,HIFU治疗组n=4、无HIFU组n=4,静脉注射共包封多柔比星和钆特醇的温度敏感脂质体,随后接受2次15分钟MR-HIFU热疗或假处理;R1图用单层IR-LL序列采集(FOV 50×69 mm,层面内分辨率0.52×0.71 mm,层厚3 mm,23个相位各130毫秒,每2分钟1幅完整R1图),与2层垂直PRFS测温层面交错(动态重复时间8.6秒,FOV 250×250 mm,层面内分辨率1.4×1.4 mm,层厚4 mm);肿瘤多柔比星浓度用荧光法测定。

关键影像表现/征象

  • 体外结果显示无论非交错还是交错IR-LL采集,测得R1值均较校准R1值轻度但一致地高估。
  • 交错PRFS序列的平均治疗单元温度时间标准差略高于非交错PRFS序列(0.186°C vs 0.101°C)。
  • 热疗后部分肿瘤大部分区域R1升高,而其他肿瘤几乎未见ΔR1变化。

诊断标准与关键数值

  • 热疗期间平均ΔR1与肿瘤多柔比星浓度线性相关(两次声辐照期间,n=8,Radj=0.933)。
  • 肿瘤冷却后测得的ΔR1与多柔比星浓度线性相关(两次声辐照平均,n=8,Radj=0.877),低于治疗期间ΔR1的相关性。
  • MR-HIFU治疗期间平均温度Taverage=40.9°C±0.3°C。

临床应用与阅片要点

  • 交错IR-LL R1图与PRFS测温可在维持测温时间分辨率的同时获取R1变化,用于估算热触发脂质体释放的药物浓度。
  • 治疗期间采集的ΔR1较肿瘤冷却后ΔR1更好地反映瘤内多柔比星浓度,提示药物递送监测宜关注治疗期间的R1变化。

局限性

  • 在体实验样本量小(HIFU治疗组n=4,无HIFU组n=4)。
  • 体外结果显示测得R1值较校准R1值轻度但一致地高估。
  • 交错PRFS序列的平均治疗单元温度时间标准差略高于非交错PRFS序列(0.186°C vs 0.101°C)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) is a method to heat lesions noninvasively to a stable, elevated temperature and a well-suited method to induce local hyperthermia (41°C-43°C) in deep-seated tissues. Magnetic Resonance (MR) imaging provides therapy planning on anatomical images and offers temperature feedback based on near-real-time MR thermometry. Although constant acquisition of MR thermometry data is crucial to ensure prolonged hyperthermia, it limits the freedom to perform measurements of other MR parameters, which are of interest during hyperthermia treatments. In image-guided drug delivery applications, co-encapsulation of paramagnetic MR contrast agents with a drug inside temperature-sensitive liposomes (TSLs) allows to visualize hyperthermia-triggered drug delivery through changes of the longitudinal relaxation rate R1. While the drug accumulates in the heated tumor tissue, R1 changes can be used for an estimate of the tumor drug concentration. The main objective of this study was to demonstrate that interleaved MR sequences are able to monitor temperature with an adequate temporal resolution and could give a reasonable estimate of the achieved tumor drug concentration through R1 changes. To this aim, in vitro validation tests and an in vivo proof-of-concept study were performed.

MATERIALS AND METHODS: All experiments were performed on a clinical 3-T MR-HIFU system adapted with a preclinical setup. The validity of the R1 values and the temperature maps stability were evaluated in phantom experiments and in ex vivo porcine muscle tissue. In vivo experiments were performed on rats bearing a 9L glioma tumor on their hind limb. All animals (n = 4 HIFU-treated, n = 4 no HIFU) were injected intravenously with TSLs co-encapsulating doxorubicin and gadoteridol as contrast agent. The TSL injection was followed by either 2 times 15 minutes of MR-HIFU-induced hyperthermia or a sham treatment. R1 maps were acquired before, during, and after sonication, using a single slice Inversion Recovery Look-Locker (IR-LL) sequence (field of view [FOV], 50 × 69 mm; in-plane resolution, 0.52 × 0.71 mm; slice thickness, 3 mm; 23 phases of 130 milliseconds; 1 full R1 map every 2 minutes). The R1 maps acquired during treatment were interleaved with 2 perpendicular proton resonance frequency shift (PRFS) MR thermometry slices (dynamic repetition time, 8.6 seconds; FOV, 250 × 250 mm; 1.4 × 1.4 mm in-plane resolution; 4 mm slice thickness). Tumor doxorubicin concentrations were determined fluorometrically.

RESULTS: In vitro results showed a slight but consistent overestimation of the measured R1 values compared with calibrated R1 values, regardless whether the R1 was acquired with noninterleaved IR-LL or interleaved. The average treatment cell temperature had a slightly higher temporal standard deviation for the interleaved PRFS sequence compared with the noninterleaved PRFS sequence (0.186°C vs 0.101°C, respectively). The prolonged time in between temperature maps due to the interleaved IR-LL sequence did not degrade the temperature stability during MR-HIFU treatment (Taverage = 40.9°C ± 0.3°C). Upon heat treatment, some tumors showed an R1 increase in a large part of the tumor while other tumors hardly showed any ΔR1. The tumor doxorubicin concentration showed a linear correlation with the average ΔR1 during both sonications (n = 8, Radj = 0.933), which was higher than for the ΔR1 measured after tumor cooldown (averaged for both sonications, n = 8, Radj = 0.877).

CONCLUSIONS: The new approach of interleaving different MR sequences was applied to simultaneously acquire R1 maps and PRFS thermometry scans during a feedback-controlled MR-HIFU-induced hyperthermia treatment. Interleaved acquisition did not compromise speed or accuracy of each scan. The ΔR1 acquired during treatment was used to visualize and quantify hyperthermia-triggered release of gadoteridol from TSLs and better reflected the intratumoral doxorubicin concentrations than the ΔR1 measured after cooldown of the tumor, exemplifying the benefit of interleaving R1 maps with temperature maps during drug delivery. Our study serves as an example for interleaved MR acquisition schemes, which introduce a higher flexibility in speed, sequence optimization, and timing.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Kneepkens E, Heijman E, Keupp J, et al. Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance-Guided High-Intensity Focused Ultrasound-Induced Hyperthermia. Invest Radiol. 2017. PMID: 28598900. doi:10.1097/RLI.0000000000000392

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。